AstraZeneca has been trying to ratchet up its rare disease efforts, spending $39 billion in 2020 to purchase Alexion and build out a new division.
Comments
(ーー゛)
There's nothing here…
AstraZeneca has been trying to ratchet up its rare disease efforts, spending $39 billion in 2020 to purchase Alexion and build out a new division.